Paul S. Swaye

Lymphocytic Myocarditis Presenting as Unexplained Ventricular Arrhythmias: Diagnosis With Endomyocardial Biopsy and Response to Immunosuppression

During a period of 18 months beginning in January 1982, a total of 65 patients were referred to the Miami Heart Institute for evaluation of either aborted out of hospital sudden death, ventricular tachycardia resistant to standard clinically directed antiarrhythmic medication programs or high grade ventricular arrhythmia (Lown class greater than or equal to IV B) with or without syncope. After complete evaluation including cardiac catheterization in all but 1 patient, 17 patients were identified in whom no obvious cardiac disease could be found. Twelve of the 17 underwent right ventricular endomyocardial biopsy. Six of the 12 biopsies demonstrated clinically unsuspected lymphocytic myocarditis (Group A). Findings in three of the remaining six biopsies were consistent with an early cardiomyopathy and in three were completely normal (Group B). Retrospective review of the clinical, laboratory, electrophysiologic, hemodynamic and angiographic data failed to identify a marker that reliably separated Group A from Group B patients. In addition to antiarrhythmic therapy guided by laboratory electrophysiologic study, all Group A patients were treated with prednisone and azathioprine. After 6 months of immunosuppression, all patients with myocarditis were reevaluated in the hospital without antiarrhythmic medication. Ventricular tachycardia/fibrillation could not be provoked in the laboratory during repeat electrophysiologic testing in five of the six patients. Repeat myocardial biopsy after all immunosuppressive therapy had been discontinued revealed absence of inflammation associated with varying degrees of residual interstitial fibrosis. There were no deaths. It was concluded that a patient with an otherwise clinically silent lymphocytic myocarditis can present with potentially life-threatening ventricular arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)

Guidelines for effective and safe percutaneous intraaortic balloon pump insertion and removal

During the 12 month period beginning February 1980, a total of 54 consecutive patients had 60 attempts at percutaneous insertion of an intraaortic balloon because of medically uncontrollable angina, cardiogenic shock either in the setting of an acute myocardial infarction or within hours of cardiac surgery and as a prophylactic measure in high risk patients before cardiac surgery. The balloon was successfully inserted in 49 patients (91 percent). In five patients the balloon could not be inserted in spite of eight attempts because of tortuosity of the iliac artery. All nine patients in whom balloon insertion was attempted without fluoroscopy had the device inserted successfully. The four insertion attempts during cardiac massage were all successful. Experience with use of the new longer introducer sheath is described. Since its acquisition there has not been a single balloon pump insertion failure in 20 consecutive patients including 6 patients in whom initial attempts through the conventional short death were unsuccessful because of iliac tortuosity. The major complications encountered in the present series were thromboembolic: femoral arterial thrombosis developed in five patients (10.2 percent) and an asymptomatic pulse loss in the contralateral foot developed in another. There were no cases of pseudoaneurysm, groin hematoma, aortic dissection or infection related to the percutaneous balloon. On the basis of this experience, several guidelines are suggested for safe and effective percutaneous insertions and removal of the intraaortic balloon pump.

Sodium nitroprusside as a coronary vasodilator in man. I. Effect of intracoronary sodium nitroprusside on coronary arteries, angina pectoris, and coronary blood flow.

Summary The effect of the intra-arterial injection of 5 to 10 μg of sodium nitroprusside on the caliber of normal and diseased coronary arteries was evaluated in 21 patients during diagnostic cardiac catheterization. In addition, the effect of intragraft injection of 5 μg of the same agent on the blood flow in aorta-right coronary artery saphenous vein bypass grafts was also evaluated intra-operatively in two patients. The compound induced an increase in the caliber of both normal and stenosed coronary arteries as well as an increase of flow in the grafts. Consistent with measurements of coronary flow response to sodium nitroprusside, angina pectoris which developed in four patients during cardiac catheterization was immediately relieved and the ischemic ST-segment depression significantly reversed after injection of 5 to 10 μg of the drug into the left main coronary artery. Within the dose range used, the drug caused no significant effect on systemic blood pressure or apparently deleterious electrophysiologic changes. No side effects were observed. We conclude that the primary direct action of sodium nitroprusside in the human coronary artery is vasodilatory.

Obscure Syncope and the Sick Sinus Syndrome

This report describes a 25‐year‐old vigorous young man who had a history of eight years of near syncope and syncope of unknown etiology. Repeat in‐hospital observation and laboratory electrophysiologic functional testing did not elucidate the origin of the symptoms. Prolonged Holler monitoring finally showed that the syncopal attacks were caused by a sick sinus syndrome (SSS). On electrophysiologic study, a concealed rate‐dependent unidirectional antegrade accessory A‐V pathway (AP) was found to be present. The AP was an incidental finding and was unrelated to the patients symptoms.

Surgical Management of the Preinfarction Syndrome

Abstract The indications for coronary reconstruction have been extended to include those patients with the preinfarction syndrome who have failed to respond to medical therapy. Preinfarction syndrome is characterized by: (1) rapidly progressive angina; (2) exacerbation of previously stable angina; and (3) recurrent bouts of coronary insufficiency. During a three-year period 60 patients with this syndrome ranging in age between 30 and 72 years underwent urgent or emergency bypass procedures. Twenty showed electrocardiographic evidence of previous myocardial infarction. Single-vessel disease (> 75% obstruction) was demonstrated by coronary angiography in 18, double-vessel disease in 14, and triple-vessel involvement in 28. The operative technique is described. Eight sustained an early and 5 a late myocardial infarction with 1 and 3 deaths, respectively. A detailed analysis of these patients is presented including restudies and pathological findings. Of the 56 survivors, only 2 continue to have incapacitating angina. From this experience we conclude that the surgical management of a selected group of patients with the preinfarction syndrome is associated with a lower mortality and an improved functional result when compared with the natural history of the syndrome.

An Unusual Form of the Bradycardia‐Tachycardia Syndrome: Paroxysmal A‐V Block and Ventricular Tachycardia

An unusual case of alternating bradycardia‐lachycardia, paroxysmal Mobitz 11 A‐V block and ventricular tachycardia is described. The patient presented with a normal resting (control) electrocardiogram and intracardiac conduction times (A‐H and H‐V intervals). The clinical evaluation, electrophysiology, and importance of defining the cause of serious rhythm disturbances prior to therapy are discussed.